High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) (HR-NBL2) (will be opening)

Principal investigator: Kim Vettenranta, Minna Koskenvuo
HUS Helsinki University Hospital, New Children´s Hospital